135 related articles for article (PubMed ID: 15804353)
1. Capreomycin is active against non-replicating M. tuberculosis.
Heifets L; Simon J; Pham V
Ann Clin Microbiol Antimicrob; 2005 Apr; 4():6. PubMed ID: 15804353
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips.
Fu LM; Shinnick TM
J Infect; 2007 Mar; 54(3):277-84. PubMed ID: 16822547
[TBL] [Abstract][Full Text] [Related]
3. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
[No Abstract] [Full Text] [Related]
4. The copper (II) ion as a carrier for the antibiotic capreomycin against Mycobacterium tuberculosis.
Manning T; Mikula R; Lee H; Calvin A; Darrah J; Wylie G; Phillips D; Bythell BJ
Bioorg Med Chem Lett; 2014 Feb; 24(3):976-82. PubMed ID: 24424129
[TBL] [Abstract][Full Text] [Related]
5. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
[TBL] [Abstract][Full Text] [Related]
6. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
Tsukamura M; Mizuno S; Murata H; Oshima T
Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
[No Abstract] [Full Text] [Related]
7. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
[TBL] [Abstract][Full Text] [Related]
8. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
Tsukamura M
Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
[No Abstract] [Full Text] [Related]
9. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
Fukuhara Y
Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
[No Abstract] [Full Text] [Related]
10. [Action and resistance mechanisms of capreomycin: a functional genomic perspective].
Liu XM; Xie JP
Yao Xue Xue Bao; 2008 Aug; 43(8):788-92. PubMed ID: 18956769
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
Lu T; Drlica K
J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
Tsukamura M; Mizuno S
J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs].
Kozulitsyna TI; Kozlova NV
Probl Tuberk; 1976 Sep; (9):70-4. PubMed ID: 64981
[No Abstract] [Full Text] [Related]
14. The determination of resistance of M. tuberculosis to capreomycin.
Schröder KH; Hensel I
Antibiot Chemother; 1970; 16():69-72. PubMed ID: 4108899
[No Abstract] [Full Text] [Related]
15. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.
Wayne LG; Sramek HA
Antimicrob Agents Chemother; 1994 Sep; 38(9):2054-8. PubMed ID: 7811018
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic luciferase reporter phage assay for active and non-replicating persistors to detect tubercle bacilli from sputum samples.
Dusthackeer VN; Balaji S; Gomathi NS; Selvakumar N; Kumar V
Clin Microbiol Infect; 2012 May; 18(5):492-6. PubMed ID: 21848970
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and in vitro extracellular and intracellular activity against Mycobacterium tuberculosis infection of new second-line antitubercular drug-palladium complexes.
Giovagnoli S; Marenzoni ML; Nocchetti M; Santi C; Blasi P; Schoubben A; Ricci M
J Pharm Pharmacol; 2014 Jan; 66(1):106-21. PubMed ID: 24341950
[TBL] [Abstract][Full Text] [Related]
18. [Experimental and clinical study test of capreomycin].
Kozlova NV; Dzhumaev B; Stepanian ES; Kaminskaia GO
Antibiotiki; 1976 Jul; 21(7):650-4. PubMed ID: 60080
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
Crowle AJ; Elkins N; May MH
Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity to ethambutol and to capreomycin in wild strains of Tubercle bacilli isolated from patients previously untreated with these drugs.
Blitek-Golc D; Zduńczyk-Pawelek H; Antosiewicz A
Pol Med J; 1971; 10(4):945-51. PubMed ID: 5001656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
